STOCK TITAN

Innovative Eyewear (LUCY) CTO trades grants and sales in 2026

(Neutral)
(Negative)
Form Type
4

Rhea-AI Filing Summary

Innovative Eyewear Inc (LUCY) reported that Chief Technology Officer David Eric Cohen had a mix of stock grants and sales. On April 2 and August 19, 2026, he received 18,200 shares of common stock each time as grant/award acquisitions at $0.00 per share. Across April 2, April 9, July 6, and August 19, 2026, he sold a total of 15,769 shares of common stock in open-market or private transactions at per-share prices ranging from $1.0436–$1.17 and a weighted average price of $0.6802 for the August 19 sale.

Positive

  • None.

Negative

  • None.
Insider Cohen David Eric
Role Chief Technology Officer
Sold 15,769 shs ($15K)
Type Security Shares Price Value
Grant/Award Common Stock 18,200 $0.00 $0.00
Sale Common Stock F1 6,136 $0.6802 $4K
Sale Common Stock 1,860 $1.17 $2K
Sale Common Stock 1,860 $1.1111 $2K
Grant/Award Common Stock 18,200 $0.00 $0.00
Sale Common Stock 5,913 $1.0436 $6K
Holdings After Transaction: Common Stock — 27,342 shares (Direct)
Footnotes (1)
  1. F1. The price reported in Column 4 is an average price of $0.6802. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
Grant on April 2, 2026 18,200 shares of Common Stock at $0.0000 per share Reported as a grant, award, or other acquisition
Grant on August 19, 2026 18,200 shares of Common Stock at $0.0000 per share Reported as a grant, award, or other acquisition
Total shares sold 15,769 shares of Common Stock Four sale transactions between April 2 and August 19, 2026
Sale on April 2, 2026 5,913 shares at $1.0436 per share Sale in open market or private transaction
Sale on April 9, 2026 1,860 shares at $1.1111 per share Sale in open market or private transaction
Sale on July 6, 2026 1,860 shares at $1.1700 per share Sale in open market or private transaction
Sale on August 19, 2026 6,136 shares at weighted average price of $0.6802 per share Sale in open market or private transaction with footnoted weighted average price
Net buy/sell shares -15,769 Form-level transaction summary netBuySellShares
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
Sale in open market or private transaction financial
"transaction_code_description: Sale in open market or private transaction"
weighted average price financial
"The price reported in Column 4 is an average price of $0.6802."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Rule 10b5-1 regulatory
"aff_10b5_one is the filing's document-level Rule 10b5-1 checkbox"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
Form 4 regulatory
"INSIDER FILING DATA (Form 4)"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

What insider transactions did LUCY’s CTO David Eric Cohen report on this Form 4?

He reported two stock grants of 18,200 shares each on April 2 and August 19, 2026, and four sales totaling 15,769 shares between April 2 and August 19, 2026, all in Innovative Eyewear Inc common stock.

How many LUCY shares did the CTO sell and at what prices?

David Eric Cohen sold 15,769 shares of Innovative Eyewear Inc common stock in four transactions at per-share prices of $1.0436, $1.1111, $1.17, and a weighted average of $0.6802 for the August 19, 2026 transaction.

What stock grants did LUCY’s CTO receive according to this filing?

He received 18,200 shares of Innovative Eyewear Inc common stock on April 2, 2026 and another 18,200 shares on August 19, 2026, both reported as grant, award, or other acquisition transactions at $0.00 per share.

Was the August 19, 2026 LUCY share sale reported at a single price?

No. The August 19, 2026 sale of 6,136 shares was reported at a weighted average price of $0.6802 per share, with the footnote stating that detailed price breakdowns within the range are available on request.

Were LUCY insider trades made under a Rule 10b5-1 trading plan?

The document-level checkbox indicating trades under a Rule 10b5-1 plan is not checked, so these transactions are not affirmed as being made pursuant to such a trading plan in this filing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Cohen David Eric

(Last)(First)(Middle)
C/O INNOVATIVE EYEWEAR INC.
11900 BISCAYNE BLVD., SUITE 630

(Street)
MIAMI FLORIDA 33181

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Innovative Eyewear Inc [ LUCY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Technology Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/02/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock04/02/2026A18,200A$0.0024,911D
Common Stock04/02/2026S5,913D$1.043618,998D
Common Stock04/09/2026S1,860D$1.111117,138D
Common Stock07/06/2026S1,860D$1.1715,278D
Common Stock08/19/2026A18,200A$0.0033,478D
Common Stock08/19/2026S6,136D$0.6802(1)27,342D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The price reported in Column 4 is an average price of $0.6802. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
/s/ Eric David Cohen08/24/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)